Herbert Y. Meltzer, M.D.
Affiliations: | Northwestern University Feinberg School of Medicine, Chicago, IL, United States |
Google:
"Herbert Meltzer"Bio:
1996-11/2011 Vanderbilt University
12/2011-present Feinberg School of Medicine Northwestern University
Mean distance: 19.85 (cluster 6)
Children
Sign in to add trainee| Alexander S. Roseman | research assistant | 2007-2008 | Vanderbilt Medical School |
| Jack P. Antel | grad student | Northwestern School of Medicine (Cell Biology Tree) | |
| John J. Panos | post-doc | 2010-2012 | Vanderbilt University Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rajagopal L, Mahjour S, Huang M, et al. (2023) NU-1223, a simplified analog of alstonine, with 5-HTR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia. Behavioural Brain Research. 114614 |
| Meltzer HY, Gadaleta E. (2021) Contrasting Typical and Atypical Antipsychotic Drugs. Focus (American Psychiatric Publishing). 19: 3-13 |
| Baltzersen OB, Meltzer HY, Frokjaer VG, et al. (2020) Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol. Frontiers in Pharmacology. 11: 591 |
| Maes MS, Lu JY, Tiwari AK, et al. (2020) Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia. Drug Development Research |
| Meltzer HY, Share DB, Jayathilake K, et al. (2020) Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia. Journal of Clinical Psychopharmacology. 40: 240-249 |
| Huang M, He W, Rajagopal L, et al. (2020) Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action. Pharmacology, Biochemistry, and Behavior. 172872 |
| Karpouzian-Rogers T, Stocks J, Meltzer HY, et al. (2019) The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia. Schizophrenia Research |
| Yoshikawa A, Li J, Meltzer HY. (2019) A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs. The Pharmacogenomics Journal |
| Huang M, He W, Kiss B, et al. (2019) The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens. The Journal of Pharmacology and Experimental Therapeutics |
| Maciukiewicz M, Tiwari AK, Zai CC, et al. (2019) Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Schizophrenia Research |